Literature DB >> 22840665

CRP level and HDL cholesterol concentration jointly predict mortality in a Korean population.

Kwang-Il Kim1, Se Won Oh, Soyeon Ahn, Nam Ju Heo, Sejoong Kim, Ho Jun Chin, Ki Young Na, Dong-Wan Chae, Cheol-Ho Kim, Suhnggwon Kim.   

Abstract

BACKGROUND: C-reactive protein (CRP) and high-density lipoprotein (HDL) cholesterol are well-known cardiovascular predictors. However, the joint effect of these parameters on long-term mortality has not been established.
METHODS: We studied a total of 92,500 subjects older than 20 years who underwent routine health examination at the three health care centers affiliated with Seoul National University. High-sensitivity CRP and the lipid profile were obtained at baseline. Subjects were followed for a median of 45.5 months. Mortality data were obtained from the National Statistics Office of Korea.
RESULTS: There were 649 deaths (0.7%) during the follow-up. The leading cause of death was cancer. The subjects who died were significantly older, had a male predominance, and had increased levels of inflammatory markers. A significant mortality difference was identified according to the CRP and HDL cholesterol levels. Considering both parameters jointly, subjects with a CRP ≥1.4 mg/L (highest quartile) and HDL cholesterol <45 mg/dL (lowest quartile) were at the highest risk for all-cause mortality, even after adjusting for covariates (hazard ratio 2.29, 95% confidence interval, 1.83~2.87). After matching on the propensity score, 6304 subjects with a high CRP and low HDL cholesterol were at high risk of death (hazard ratio 2.52, 95% confidence interval, 1.59~4.01). Interestingly, the joint effect of CRP and HDL cholesterol was observed for cardiovascular as well as cancer-related mortality prediction.
CONCLUSIONS: Elevated CRP and low HDL cholesterol jointly contribute to the prediction of all-cause, cancer, and cardiovascular mortality in Koreans. The interactive relationship between them in mediating inflammatory processes might explain these results.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22840665     DOI: 10.1016/j.amjmed.2012.02.013

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

1.  Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial.

Authors:  James D Otvos; John R Guyton; Margery A Connelly; Sydney Akapame; Vera Bittner; Steven L Kopecky; Megan Lacy; Santica M Marcovina; Joseph B Muhlestein; William E Boden
Journal:  J Clin Lipidol       Date:  2018-01-12       Impact factor: 4.766

2.  HDL anti-oxidant function associates with LDL level in young adults.

Authors:  Carrie V Breton; Fen Yin; Xinhui Wang; Ed Avol; Frank D Gilliland; Jesus A Araujo
Journal:  Atherosclerosis       Date:  2013-11-15       Impact factor: 5.162

3.  C-reactive Protein Concentration Is Associated With a Higher Risk of Mortality in a Rural Korean Population.

Authors:  Jung Hyun Lee; Hyungseon Yeom; Hyeon Chang Kim; Il Suh; Mi Kyung Kim; Min-Ho Shin; Dong Hoon Shin; Sang-Baek Koh; Song Vogue Ahn; Tae-Yong Lee; So Yeon Ryu; Jae-Sok Song; Hong-Soon Choe; Young-Hoon Lee; Bo Youl Choi
Journal:  J Prev Med Public Health       Date:  2016-08-23

4.  Combined associations of hs-CRP and cognitive function with all-cause mortality among oldest-old adults in Chinese longevity areas: a prospective cohort study.

Authors:  Chen Chen; Yingchun Liu; Zhaojin Cao; Zhaoxue Yin; Feng Zhao; Yuebin Lv; Zuyun Liu; Chen Mao; Shixun Song; Ling Liu; Yingli Qu; Saisai Ji; Jun Duan; Jiaonan Wang; Virginia Byers Kraus; Yi Zeng; Xiaoming Shi
Journal:  Immun Ageing       Date:  2019-11-17       Impact factor: 6.400

5.  Inflammatory metabolic profile of South African patients with prostate cancer.

Authors:  Stefano Cacciatore; Martha Wium; Cristina Licari; Aderonke Ajayi-Smith; Lorenzo Masieri; Chanelle Anderson; Azola Samkele Salukazana; Lisa Kaestner; Marco Carini; Giuseppina M Carbone; Carlo V Catapano; Massimo Loda; Towia A Libermann; Luiz F Zerbini
Journal:  Cancer Metab       Date:  2021-08-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.